Loading...

Menu

Καταχωρήθηκε: Τετάρτη 22 Μάρ 2017

 

NGS analysis has prognostic and therapeutic implications. A validated NGS analysis in AML samples is now available.
The analysis is performed at the Karaiskakeio Foundation. Samples can be sent for preparation at the BMT Laboratory of University of Patras

Agilent Acute Myeloid Leukemia (AML) Panel

NRAS, TP53, ASXL1, FLT3, IDH1, IDH2, JAK2, JAK3, NPM1, RUNX1, CBL, CEBPA, CSF3R, DNMT3A, EZH2, MPL, SF3B2, SRSF2, TET2, U2AF1.

AML panel (NGS).  
code: 12600 SOMATIC MUTATION PANEL (NGS SEQUENCING)
 cost: 850.00 Euro
sample: 1ml BM sample  

OTHER NGS PANELS AVAILABLE

Agilent Cancer Panel

NRAS, ASXL1, FLT3, IDH1, IDH2, JAK2, JAK3, NPM1, RUNX1, SMAD4, ALK, ATM , CDKN2A, PTEN , STK11, ABL1, AKT1, BRAF , CSF1R , CTNNB1, EGFR , ERBB2, ERBB4, FANCA, FANCC, FANCF, FANCG , FGFR1, FGFR2, FGFR3, HRAS, KIT, KRAS, MAP2K1, MAP2K2, MAP2K4, MET, NOTCH1, PDGFRA, PIK3CA, PIK3R1, RET, SMO, SRC, VHL, WT1.

Inherited Cancer Panel

APC, ATM, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDK4, CDKN2A, EPCAM, FH, FLCN, MLH1, MSH2, MSH6, MUTYH, NBN, NTHL1, PALB2, PMS2, POLD1, POLE, PTEN, RAD51C, RAD51D, SMAD4, STK11, TP53.

Neuroblastoma Gene Panel

ALK, ARID1A, ARID1B, ATRX, BARD1, CHD9, CHEK2, MYCN, NRAS, PHOX2B, PINK1, PTPN11, TP53.

Familial Hemophagocytic Lymphohistiocytosis (HLH) Panel

HLH: familial hemophagocytic lymphohistiocytosis, X- linked lymphoproliferative (XLP) syndromes 1 and 2, XMEN syndrome and lysinuric protein intolerance, Griscelli Syndrome with Hemophagocytic Syndrome, Chediak-Higashi syndrome, Hermansky Pudlak syndrome types 2 and 9, CD27 deficiency, ITK deficiency: AP3B1, BLOC1S6, CD27, ITK, LYST, PRF1, SH2D1A, SLC7A7, STX11, STXBP2, UNC13-D, XIAP, RAB27A.

Diamond Blackfan Anemia Panel

RPL11, RPL15, RPL26, RPL35A, RPL5, RPS10, RPS17, RPS19, RPS24, RPS26, RPS28, RPS29, RPS7, TSR2.

Fancony Anemia Panel

FANCA, FANCC, FANCF, FANCG, BRIP1 (FANCJ), PALB2 (FANCN), RAD51C (FANCO), BRCA2, ERCC4 (FANCQ), FANCB, FANCD2, FANCE, FANCI, FANCL, FANCM, SLX4 (FANCP).

Bone Marrow Failure/Severe Combined Neutropenia Panel

Severe Congenital Neutropenia (SCN1-5), GATA1-related X-linked cytopenia, GATA2 deficiency, p14 deficiency, Chediak Higashi syndrome, Congenital amegakaryocytic thrombocytopeniam, WHIM syndrome, Griscelli syndrome type 2, Hermansky Pudlak type 2, Severe congenital neutropenia (germline); predisposition to MDS (somatic), Neutrophil immunodeficiency syndrome, Shwachman Diamond syndrome (SDS), Glycogen storage disease type IB, Familial bone marrow failure syndrome, Barth syndrome, Clericuzio-type poikiloderma with neutropenia, Cohen syndrome; congenital neutropenia with retinopathy, Wiskott Aldrich syndrome, X-linked: AP3B1, CSF3R, CXCR4, ELANE (ELA2), G6PC3, GATA1, GATA2, GFI1, HAX1, LAMTOR2 (ROBLD3), LYST, MPL, RAB27A, RAC2, SBDS, SLC37A4, SRP72, TAZ, USB1, VPS13B, VPS45, WAS.

Neurofibromatosis Gene Sequencing (NGS)

NF1, NF2

Chromosome Breakage Syndromes Panel

Ataxia-Telangiectasia, Bloom syndrome, Nijmegen breakage syndrome, LIG4 syndrome and NHEJ1 deficiency: ATM, BLM, LIG4, NBN, NHEJ1

 

 

Τηλέφωνα Επικοινωνίας:

 

Γραμματεία MMMO: 2613 603506 (ασθενείς), 2613 604062 (Γραμματεία Διευθυντή) 
Fax : 2613 604066,
email (για ιατρούς): transplant@upatras.gr,
email (για ασθενείς): mmak@upatras.gr
email (για θέματα κλινικών μελετών) : gcppatras@gmail.com
Μονάδα Μεταμόσχευσης (Νοσηλεία): 2613 603 261
Γραφείο Ιατρών: 2613 604064, 2613 604065,
Εφημερεύων Ιατρός: 2610 999111 (τηλ. κέντρο ΠΓΝΠ)

 

βρείτε μας στο χάρτη

 

Login / Sitemap

 

© Copyright 2015 - 2024 Μονάδα Μεταμόσχευσης Μυελού των Οστών Πάτρας